Cited by 108Epigenetics and DNA MethylationGenomics and Chromatin DynamicsChromatin Remodeling and Cancer

Epigenetic Regulation of Cell Type–Specific Expression Patterns in the Human Mammary Epithelium

Open access
Maruyama, Reo, Choudhury, Sibgat, Kowalczyk, Adam, Bessarabova, Marina, Beresford-Smith, Bryan, Conway, Thomas, Kaspi, Antony, Wu, Zhenhua +8 more·2011·PLoS Genetics

Abstract

Differentiation is an epigenetic program that involves the gradual loss of pluripotency and acquisition of cell type-specific features. Understanding these processes requires genome-wide analysis of epigenetic and gene expression profiles, which have been challenging in primary tissue samples due to limited numbers of cells available. Here we describe the application of high-throughput sequencing technology for profiling histone and DNA methylation, as well as gene expression patterns of normal human mammary progenitor-enriched and luminal lineage-committed cells. We observed significant differences in histone H3 lysine 27 tri-methylation (H3K27me3) enrichment and DNA methylation of genes expressed in a cell type-specific manner, suggesting their regulation by epigenetic mechanisms and a dynamic interplay between the two processes that together define developmental potential. The technologies we developed and the epigenetically regulated genes we identified will accelerate the characterization of primary cell epigenomes and the dissection of human mammary epithelial lineage-commitment and luminal differentiation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1001369

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • During tumorigenic progression, loss of expression of tumor suppressors RB1, BRCA1, APC, MLH1, and VHL has been observed due to hypermethylation at the promoter level.

    “To cite an example, during tumorigenic progression, the loss of the expression of tumor suppressors—such as RB1; breast cancer type 1, BRCA1; anaphase promoting complex, APC; DNA mismatch repair protein MLH1; and Von Hippel–Lindau tumor suppressor VHL—has been observed due to hypermethylation at the promoter level.”

    From Revisiting Epigenetics Fundamentals and Its Biomedical Implications (2024) · cites this paper as [88]

    The Results section on cell type–specific DNA methylation patterns (page unavailable) reports that methylation near promoters is associated with lower gene expression in mammary epithelial cells. It does not report promoter hypermethylation causing loss of RB1, BRCA1, APC, MLH1, or VHL expression during tumorigenic progression. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In cancer, epigenetic dysregulation involves ncRNAs, particularly miRNAs and lncRNAs, as well as alterations in methylation and acetylation.

    “In cancer, epigenetic dysregulation involves ncRNAs, in particular miRNAs, and lncRNAs, which comprise the most studied RNAs, as well as alterations in methylation and acetylation [88].”

    From Revisiting Epigenetics Fundamentals and Its Biomedical Implications (2024) · cites this paper as [88]

    The Introduction (page unavailable) says that DNA methylation, histone modification, and non-coding RNAs play roles in tumorigenesis. It does not identify miRNAs or lncRNAs, say they are the most studied RNAs, or specify acetylation; the Results passages instead discuss histone methylation. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • miRNAs target the BACE1 protein that regulates the production of amyloid beta platelets, Aβ, which when accumulated contribute to neuroinflammation and progression of Alzheimer's disease.

    “Likewise, it has been reported that there are miRNAs that target the BACE1 protein that regulates the production of amyloid beta platelets, Aβ, which, when accumulated, contribute to the neuroinflammation and progression of this disease [86,87,88].”

    From Revisiting Epigenetics Fundamentals and Its Biomedical Implications (2024) · cites this paper as [88]

    The Results passage on gene expression and histone modification patterns and the Discussion passage on K27-regulated transcription factors concern human mammary epithelial cells. Searches for BACE1, miRNAs, amyloid beta, neuroinflammation, and Alzheimer’s disease found no passage in our copy addressing the attributed claim. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • In Alzheimer's disease, changes have been identified in the methylation status of CLU, ABCA7, MS4A6A, and CD2AP, which have been reported to contribute to the development of the disease.

    “On the other hand, in Alzheimer’s disease, for example, changes have been identified in the methylation status of proteins such as human clusterin CLU; ATP binding cassette subfamily A member 7 ABCA7; MS4A6A; and CD2AP, which have been reported to contribute to the development of the disease.”

    From Revisiting Epigenetics Fundamentals and Its Biomedical Implications (2024) · cites this paper as [88]

    The Results section on cell type–specific DNA methylation examines CD24+ and CD44+ human mammary epithelial cells, not Alzheimer’s disease. Searches for Alzheimer’s disease and the named genes (CLU, ABCA7, MS4A6A, and CD2AP) found no passage in our copy addressing their methylation or contribution to the disease. No page numbers were available in the indexed passages. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 108

Research works printed but not linked: 36

  1. [1]Graf T Enver T 2009 Forcing cells to change lineages. Nature 462 587 594 19956253
  2. [2]Lister R Pelizzola M Dowen RH Hawkins RD Hon G 2009 Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462 315 322 19829295 PMC2857523
  3. [3]Bernstein BE Mikkelsen TS Xie X Kamal M Huebert DJ 2006 A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 315 326 16630819
  4. [4]Ku M Koche RP Rheinbay E Mendenhall EM Endoh M 2008 Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4 e1000242 doi: 10.1371/journal.pgen.1000242 18974828 PMC2567431 · DOI
  5. [5]Stingl J Raouf A Emerman JT Eaves CJ 2005 Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia 10 49 59 15886886
  6. [6]Clarke RB Spence K Anderson E Howell A Okano H 2005 A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277 443 456 15617686
  7. [7]Gudjonsson T Villadsen R Nielsen HL Ronnov-Jessen L Bissell MJ 2002 Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16 693 706 11914275 PMC155359
  8. [8]Dontu G Abdallah WM Foley JM Jackson KW Clarke MF 2003 In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17 1253 1270 12756227 PMC196056
  9. [9]Alvi AJ Clayton H Joshi C Enver T Ashworth A 2003 Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 5 R1 8 12559051 PMC154129
  10. [10]Clayton H Titley I Vivanco M 2004 Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp Cell Res 297 444 460 15212947
  11. [11]Raouf A Zhao Y To K Stingl J Delaney A 2008 Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3 109 118 18593563
  12. [12]Eirew P Stingl J Raouf A Turashvili G Aparicio S 2008 A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 14 1384 1389 19029987
  13. [13]Ginestier C Hur MH Charafe-Jauffret E Monville F Dutcher J 2007 ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell 1 555 567 18371393 PMC2423808
  14. [14]Mani SA Guo W Liao MJ Eaton EN Ayyanan A 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 704 715 18485877 PMC2728032
  15. [15]Liu S Dontu G Mantle ID Patel S Ahn NS 2006 Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66 6063 6071 16778178 PMC4386278
  16. [16]Shipitsin M Campbell LL Argani P Weremowicz S Bloushtain-Qimron N 2007 Molecular definition of breast tumor heterogeneity. Cancer Cell 11 259 273 17349583
  17. [17]Bloushtain-Qimron N Yao J Snyder EL Shipitsin M Campbell LL 2008 Cell type–specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 105 14076 14081 18780791 PMC2532972
  18. [20]Mikkelsen TS Ku M Jaffe DB Issac B Lieberman E 2007 Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 553 560 17603471 PMC2921165
  19. [21]Park PJ 2009 ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 10 669 680 19736561 PMC3191340
  20. [22]Hu M Yao J Cai L Bachman KE van den Brule F 2005 Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37 899 905 16007089
  21. [23]Velculescu VE Zhang L Vogelstein B Kinzler KW 1995 Serial analysis of gene expression. Science 270 484 487 7570003
  22. [24]Ramalho-Santos M Yoon S Matsuzaki Y Mulligan RC Melton DA 2002 “temness” transcriptional profiling of embryonic and adult stem cells. Science 298 597 600 12228720
  23. [25]Katoh M 2010 Network of WNT and Other Regulatory Signaling Cascades in Pluripotent Stem Cells and Cancer Stem Cells. Curr Pharm Biotechnol 21044011
  24. [26]Kouros-Mehr H Slorach EM Sternlicht MD Werb Z 2006 GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127 1041 1055 17129787 PMC2646406
  25. [27]Asselin-Labat ML Sutherland KD Barker H Thomas R Shackleton M 2007 Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9 201 209 17187062
  26. [28]Zang C Schones DE Zeng C Cui K Zhao K 2009 A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25 1952 1958 19505939 PMC2732366
  27. [29]Nikolsky Y Kirillov E Zuev R Rakhmatulin E Nikolskaya T 2009 Functional analysis of OMICs data and small molecule compounds in an integrated “nowledge-based”platform. Methods Mol Biol 563 177 196 19597786
  28. [30]Lupien M Eeckhoute J Meyer CA Wang Q Zhang Y 2008 FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132 958 970 18358809 PMC2323438
  29. [31]Sanz LA Chamberlain S Sabourin JC Henckel A Magnuson T 2008 A mono-allelic bivalent chromatin domain controls tissue-specific imprinting at Grb10. Embo J 27 2523 2532 18650936 PMC2567399
  30. [32]Rodriguez J Munoz M Vives L Frangou CG Groudine M 2008 Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci U S A 105 19809 19814 19060200 PMC2596747
  31. [33]Hanna JH Saha K Jaenisch R 2010 Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143 508 525 21074044 PMC3032267
  32. [34]Zhang X Yazaki J Sundaresan A Cokus S Chan SW 2006 Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell 126 1189 1201 16949657
  33. [35]Jones PA 1999 The DNA methylation paradox. Trends Genet 15 34 37 10087932
  34. [36]Polyak K Weinberg RA 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9 265 273 19262571
  35. [37]Mohn F Weber M Rebhan M Roloff TC Richter J 2008 Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30 755 766 18514006
  36. [38]Akkers RC van Heeringen SJ Jacobi UG Janssen-Megens EM Francoijs KJ 2009 A hierarchy of H3K4me3 and H3K27me3 acquisition in spatial gene regulation in Xenopus embryos. Dev Cell 17 425 434 19758566 PMC2746918

Authors
Maruyama, R., Choudhury, S., Kowalczyk, A., Bessarabova, M., Beresford-Smith, B., Conway, T., Kaspi, A., Wu, Z., Nikolskaya, T., Merino, V. F., Lo, P.-K., Liu, X. S., Nikolsky, Y., Sukumar, S., Haviv, I., & Polyak, K.
Affiliations
  • Brigham and Women's Hospital (US)
  • The University of Melbourne (AU)
  • Thomson Reuters (United States) (US)
  • Baker Heart and Diabetes Institute (AU)
  • Harvard University (US)
  • Johns Hopkins University (US)
Venue
PLoS Genetics
Published
2011-04-21
Volume
7
Issue
4
Pages
e1001369
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2011155783
Cited by
108
References
40
Citations by year
2026: 2 · 2025: 1 · 2024: 6 · 2023: 4 · 2022: 11 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 13 · 2015: 11 · 2014: 8 · 2013: 11 · 2012: 8
FWCI
3.77
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Susan G. Komen for the Cure
  • Breast Cancer Research Foundation
  • Brigham and Women's Hospital
  • Johns Hopkins University
  • Canada's Michael Smith Genome Sciences Centre
  • Terri Brodeur Breast Cancer Foundation
  • BC Cancer Agency
  • National Cancer Institute (CA 89393, P50 CA 89393, CA080111, P01CA080111, P50CA089393)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
epigenetic regulation, mammary epithelium, mammary progenitor cells, luminal differentiation, H3K27me3, DNA methylation, histone methylation, cell type-specific gene expression, lineage commitment, developmental potential
MeSH terms
Cell Differentiation, Chromatin, Gene Expression Regulation, Histones, Humans, Transcription Factors, Hyaluronan Receptors, DNA Methylation, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mammary Glands, Human, Epigenesis, Genetic, CD24 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review